Sage Journals: Discover world-class research

Retricted access

Other

First published 2009-7

Content Analysis of FDA Warning Letters to Manufacturers of Pharmaceuticals and Therapeutic Biologicals for Promotional Violations

Khalid M. Kamal, Shane P. Desselle, Pallavi Rane [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1983-4

FDA Policy on Comparative Prescription Drug Advertising

Lloyd G. Millstein

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1983-7

FDA Approval of Comparative Claims for Prescription Drugs-The Moxam Case

Daniel Marcus

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2011-6

The Ban on “Off-Label” Pharmaceutical Promotion: Constitutionally Permissible Prophylaxis against False or Misleading Commercial Speech?

Kate Greenwood

American Journal of Law & Medicine

Retricted access

Research article

First published 1973-12

Patterns of Prescription Drug Use: The Role of Promotion

C. Joseph Stetler

Journal of Drug Education: Substance Use Research and Prevention

Retricted access

Research article

First published 2014-9

Promotion of Patient-Reported Outcome Label Claims Based on Nonprimary Endpoints

Ari Gnanasakthy, Ashlyn Sadrick, Mariam Eghbal-Ahmadi [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1986-10

Drug Promotion: The Third World Revisited

Milton Silverman, Philip R. Lee, Mia Lydecker

International Journal of Social Determinants of Health and Health Services

Retricted access

Other

First published 2007-5

Prescription Drug Advertising and Promotion: Learnings from Recent Food and Drug Administration Warning Letters

Eric B. Benson, Sherman N. Alfors

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2021-12

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Kimberly G. Wagoner, Allison J. Lazard, E. Alfonso Romero-Sandoval [...]

Cannabis & Cannabinoid Research

Retricted access

Research article

First published 2016-5

A Critical Review of the Marketing Claims of Infant Formula Products in the United States

Peter F. Belamarich, Risa E. Bochner, Andrew D. Racine

Clinical Pediatrics

Search results